Critical investigation of the CD14 promoter polymorphism: Lack of a role for in vitro cytokine response and membrane CD14 expression

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 10, 2005, Pages 1254-1256

  Von Aulock, Sonja ^a   Rupp, Jan ^b   Gueinzius, Katja ^a   Maass, Matthias ^b   Hermann, Corinna ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BACILLUS SUBTILIS; BORRELIA; BORRELIA BURGDORFERI; CANDIDA ALBICANS; CHLAMYDOPHILA PNEUMONIAE; CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOSTIMULATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; VOLUNTEER;

ANTIGENS, CD14; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; IMMUNITY; LIPOPOLYSACCHARIDES; MONOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 26944479246     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.10.1254-1256.2005     Document Type: Article

References (16)

1. Amar, J., J. B. Ruidavets, C. Bal dit Sollier, V. Bongard, H. Boccalon, B. Chamontin, L. Drouet, and J. Ferrieres. 2004. CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J. Hypertens. 22:1523-1528.
2. Baldini, M., I. C. Lohman, M. Halonen, R. P. Erickson, P. G. Holt, and F. D. Martinez. 1999. A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell Mol. Biol. 20:976-983.
3. Eng, H. L., C. H. Wang, C. H. Chen, M. H. Chou, C. T. Cheng, and T. M. Lin. 2004. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun. 5:426-430.
4. Hartung, T., W. D. Docke, F. Gantner, G. Krieger, A. Sauer, P. Stevens, H. D. Volk, and A. Wendel. 1995. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482-2489.
5. Heesen, M., B. Blomeke, B. Schluter, N. Heussen, R. Rossaint, and D. Kunz. 2001. Lack of association between the -260 C->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intens. Care Med. 27:1770-1775.
6. Hubacek, J. A., G. Rothe, J. Pit'ha, Z. Skodova, V. Stanek, R. Poledne, and G. Schmitz. 1999. C(-260)->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99:3218-3220.
7. Hung, J., B. M. McQuillan, C. M. Chapman, P. L. Thompson, and J. P. Beilby. 2004. Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community population. Eur. J. Cardiovasc. Prev. Rehabil. 11:344-349.
8. Ito, D., M. Murata, N. Tanahashi, H. Sato, A. Sonoda, I. Saito, K. Watanabe, and Y. Fukuuchi. 2000. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 31:2661-2664.
9. Koch, W., A. Kastrati, J. Mehilli, N. von Beckerath, and A. Schomig. 2002. CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am. Heart J. 143:971-976.
10. Kondo, T., M. Ohne, K. Shimokata, S. Iino, Y. Inden, T. Murohara, and M. Hirai. 2003. CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis. Heart 89:931-932.
11. LeVan, T. D., J. W. Bloom, T. J. Bailey, C. L. Karp, M. Halonen, F. D. Martinez, and D. Vercelli. 2001. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 167:5838-5844.
12. Longobardo, M. T., A. B. Cefalu, F. Pezzino, D. Noto, G. Emmanuele, C. M. Barbagallo, B. Fiore, R. Monastero, A. Castello, V. Molini, A. Notarbartolo, S. Travali, and M. R. Averna. 2003. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin. Exp. Med. 3:161-165.
13. Morange, P. E., L. Tiret, N. Saut, G. Luc, D. Arveiler, J. Ferneres, P. Amouyel, A. Evans, P. Ducimetiere, F. Cambien, and I. Juhan-Vague. 2004. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME Study. Eur. J. Hum. Genet. 12:1041-1049.
14. Unkelbach, K., A. Gardemann, M. Kostrzewa, M. Philipp, H. Tillmanns, and W. Haberbosch. 1999. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler. Thromb. Vasc. Biol. 19:932-938.
15. von Aulock, S., N. W. Schroder, K. Gueinzius, S. Traub, S. Hoffmann, K. Graf, S. Dimmeler, T. Hartung, R. R. Schumann, and C. Hermann. 2003. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J. Infect. Dis. 188:938-943.
16. Zee, R. Y., K. Lindpaintner, B. Struk, C. H. Hennekens, and P. M. Ridker. 2001. A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 154:699-702.